<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://en.bharatpedia.org/w/index.php?action=history&amp;feed=atom&amp;title=Minoxidil%2Ffinasteride</id>
	<title>Minoxidil/finasteride - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://en.bharatpedia.org/w/index.php?action=history&amp;feed=atom&amp;title=Minoxidil%2Ffinasteride"/>
	<link rel="alternate" type="text/html" href="https://en.bharatpedia.org/w/index.php?title=Minoxidil/finasteride&amp;action=history"/>
	<updated>2026-10-24T13:51:41Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://en.bharatpedia.org/w/index.php?title=Minoxidil/finasteride&amp;diff=517751&amp;oldid=prev</id>
		<title>Doonedu: new the data needs work</title>
		<link rel="alternate" type="text/html" href="https://en.bharatpedia.org/w/index.php?title=Minoxidil/finasteride&amp;diff=517751&amp;oldid=prev"/>
		<updated>2025-10-27T04:51:38Z</updated>

		<summary type="html">&lt;p&gt;new the data needs work&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{cs1 config|name-list-style=vanc|display-authors=6}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| drug_name = &lt;br /&gt;
| type = combo&lt;br /&gt;
| image = Minoxidil structure.svg&lt;br /&gt;
| image_class = skin-invert-image&lt;br /&gt;
| width = 150px&lt;br /&gt;
| alt = &lt;br /&gt;
| caption = [[Minoxidil]]&lt;br /&gt;
| image2 = Finasteride.svg&lt;br /&gt;
| image_class2 = skin-invert-image&lt;br /&gt;
| width2 = 250px&lt;br /&gt;
| alt2 = &lt;br /&gt;
| caption2 = [[Finasteride]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- Combo data --&amp;gt;&lt;br /&gt;
| component1 = Minoxidil&lt;br /&gt;
| class1 = [[Potassium channel opener]]&lt;br /&gt;
| component2 = Finasteride&lt;br /&gt;
| class2 = [[5α-Reductase inhibitor]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- Clinical data --&amp;gt;&lt;br /&gt;
| tradename = MorrF; Morr F&lt;br /&gt;
| Drugs.com = &lt;br /&gt;
| MedlinePlus = &lt;br /&gt;
| pregnancy_AU = &amp;lt;!-- A, B1, B2, B3, C, D, X --&amp;gt;&lt;br /&gt;
| pregnancy_category = &lt;br /&gt;
| routes_of_administration = [[Topical medication|Topical]]&amp;lt;ref name=&amp;quot;AdisInsight&amp;quot; /&amp;gt;&lt;br /&gt;
| class = [[Hair loss medication]]&lt;br /&gt;
| ATC_prefix = &lt;br /&gt;
| ATC_suffix = &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- Legal status --&amp;gt;&lt;br /&gt;
| legal_AU = &amp;lt;!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--&amp;gt;&lt;br /&gt;
| legal_CA = &amp;lt;!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --&amp;gt;&lt;br /&gt;
| legal_UK = &amp;lt;!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM --&amp;gt;&lt;br /&gt;
| legal_US = &amp;lt;!-- OTC, Rx-only, Schedule I, II, III, IV, V --&amp;gt;&lt;br /&gt;
| legal_EU = &lt;br /&gt;
| legal_EU_comment = &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- Identifiers --&amp;gt;&lt;br /&gt;
| CAS_number = &lt;br /&gt;
| PubChem = &lt;br /&gt;
| DrugBank = &lt;br /&gt;
| synonyms = Finasteride/minoxidil&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Minoxidil/finasteride&amp;#039;&amp;#039;&amp;#039;, or &amp;#039;&amp;#039;&amp;#039;finasteride/minoxidil&amp;#039;&amp;#039;&amp;#039;, sold under the brand name &amp;#039;&amp;#039;&amp;#039;MorrF&amp;#039;&amp;#039;&amp;#039; or &amp;#039;&amp;#039;&amp;#039;Morr F&amp;#039;&amp;#039;&amp;#039;, is a [[combination drug|combination]] of the [[ATP-sensitive potassium channel|K&amp;lt;sub&amp;gt;ATP&amp;lt;/sub&amp;gt;]] [[potassium channel opener]] [[minoxidil]] and the [[5α-reductase inhibitor]] [[finasteride]] which is approved and used in the treatment of [[alopecia]] (hair loss) in [[India]].&amp;lt;ref name=&amp;quot;AdisInsight&amp;quot;&amp;gt;{{cite web | title = Jina Pharmaceuticals/Intas Pharmaceuticals | date = 2 September 2015 | website = AdisInsight | url = https://adisinsight.springer.com/drugs/800043157 | access-date = 23 October 2025 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Ramkar_2023&amp;quot;&amp;gt;{{cite journal | vauthors = Ramkar S, Kaurav M, Sudheesh MS, Pandey RS | title = Enhanced skin penetration of Finasteride loaded DMSO-liposomes for the treatment of androgenic alopecia: comparison with conventional liposomes | journal = Drug Development and Industrial Pharmacy | volume = 49 | issue = 1 | pages = 52–61 | date = January 2023 | pmid = 36803490 | doi = 10.1080/03639045.2023.2182122 }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;van_Hoogevest_2021&amp;quot;&amp;gt;{{cite journal | vauthors = van Hoogevest P, Tiemessen H, Metselaar JM, Drescher S, Fahr A | title = The Use of Phospholipids to Make Pharmaceutical Form Line Extensions | journal = European Journal of Lipid Science and Technology | volume = 123 | issue = 4 | date = 2021 | article-number = 2000297 | doi = 10.1002/ejlt.202000297 | issn = 1438-7697 | url = https://onlinelibrary.wiley.com/doi/10.1002/ejlt.202000297 | access-date = 23 October 2025 | url-access = subscription }}&amp;lt;/ref&amp;gt; It is used [[topical medication|topically]].&amp;lt;ref name=&amp;quot;AdisInsight&amp;quot; /&amp;gt; The drug was developed by Intas Pharmaceuticals and Jina Pharmaceuticals and was introduced in 2015.&amp;lt;ref name=&amp;quot;AdisInsight&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
{{Other dermatological preparations}}&lt;br /&gt;
{{Androgens and antiandrogens}}&lt;br /&gt;
{{Ion channel modulators}}&lt;br /&gt;
&lt;br /&gt;
[[Category:5α-Reductase inhibitors]]&lt;br /&gt;
[[Category:Combination drugs]]&lt;br /&gt;
[[Category:Potassium channel openers]]&lt;br /&gt;
&lt;br /&gt;
{{Dermatologic-drug-stub}}&lt;/div&gt;</summary>
		<author><name>Doonedu</name></author>
	</entry>
</feed>